Prescription drug dependency is clinical addiction to supportive care that were — at least initially — taken under clinical direction or purchased for a legitimate symptom. In India, the pattern runs across four main drug categories, affects a wide demographic, and is substantially under-recognised by the families it affects because the substances arrived through a pharmacy, not a dealer.
For families, this matters for a specific reason: the signs of prescription dependency are often missed because everyone assumes "the doctor started it, so it must be fine." That assumption is wrong in a large and growing number of cases.
Why prescription dependency is different
Three features distinguish prescription addiction from street drug addiction, and each has implications for how families respond.
First, the substances are legal when started, which means the person is not hiding a criminal activity. They are simply taking tablets or syrup. Family members often do not know dependency is developing until it is well-established.
Second, dependency often starts from a real clinical need. A genuine injury, genuine anxiety, genuine pain. The slide from treatment to dependency is gradual and does not feel like the classic addiction narrative.
Third, withdrawal from several prescription drug classes — particularly sedatives — is clinically serious. Sudden cessation can produce seizures. This rules out several of the informal strategies that families try first.
The four categories that matter in India
Opioid painkillers — opioid or sedative misuse, prescription substance
support is the dominant prescription opioid in Indian dependency cases. Originally positioned as a weaker, safer opioid, it has been widely over-started and is now one of the most-seen substances in addiction counselling and rehabilitation practice. support is usually consumed as a cough syrup (clinically supervised formulations are still widely available despite restrictions) and has its own subculture of dependency. prescription substance is a newer entrant showing the same pattern.
sedatives — support (prescription substance, prescription substance), sedative substance misuse
started for anxiety, insomnia, or panic. Tolerance develops within weeks, and dependency within months. Patients escalate dose to achieve the same effect, source from multiple doctors or pharmacies, and experience significant withdrawal on any attempt to stop. sedative dependency is particularly common among middle-aged urban women who began using them for sleep years earlier.
prescription substanceoids — prescription substance (Lyrica), prescription substance
started for nerve pain, anxiety, and fibromyalgia. Misuse has grown substantially in the last decade — particularly as a supplement to other substances. Produces calming and euphoric effects at higher doses. Withdrawal produces severe anxiety, insomnia, and rebound pain.
Stimulants — prescription substance (Ritalin, Concerta), prescription substance
Less common than the first three but growing — particularly among students and working professionals seeking cognitive enhancement. Dependency is psychological more than physical, but the pattern is clinically recognisable.
How dependency typically develops
A representative case: a thirty-eight-year-old executive develops chronic back pain after a minor accident. His doctor reviews support for two weeks. The pain improves but has not resolved at the end of the course, and he asks for a refill. Over the next year, he obtains support from three different doctors, then from a pharmacy that does not ask for fresh prescriptions. His dose has risen from 50mg twice daily to 100mg four times daily. He has started feeling anxious and restless if he misses a dose. The "back pain" he is now treating is, clinically, support withdrawal. His family thinks he is on a long-term pain supportive care. He himself is not fully aware of what has happened.
Variations of this story — with different drugs, different symptoms, different durations — make up a substantial fraction of our admissions. The common thread is that nobody made a decision to become dependent. The dependency developed through a series of reasonable-looking small decisions, each of which made sense in isolation.
Why stopping suddenly is dangerous
This is the single most important point in this article. Stopping sedatives abruptly can produce seizures that are potentially fatal. Stopping high-dose opioids abruptly produces severe withdrawal. Stopping prescription substanceoids abruptly produces severe anxiety and sleep disruption. In all cases, supervised supervised support is required.
This is non-negotiable. Sedative withdrawal can produce seizures and, in severe cases, be fatal. If the person in your family is on regular opioid or sedative misuse, or support and is contemplating stopping, that conversation should happen with a psychiatrist, not at the kitchen table.
The common family mistake — "I'll just throw away his pills and make him tough it out" — is dangerous with prescription drug dependency. It is the one scenario where cold turkey is not just hard but clinically contraindicated.
The treatment pathway
At SimranShri, prescription drug dependency is treated on the same residential framework as other substance dependencies, with specific clinical adjustments.
- Days 1-3: Clinical assessment. Exact drug, dose, frequency, and duration of use are documented. Toxicology confirms the profile. Psychiatric evaluation identifies any underlying condition (e.g. anxiety disorder) that the supportive care was originally started for.
- Days 3-14: clinically supervised support. The rate of support depends on the drug class — sedatives may support over weeks, opioids faster, prescription substanceoids more gradually. Withdrawal symptoms are managed with supportive care.
- Weeks 3-10: Intensive therapy phase. CBT for dependency-related patterns, work on the original condition the supportive care was addressing, family sessions, trigger mapping.
- Weeks 10+: Discharge planning with specific attention to the original health condition. Handover to a psychiatrist or physician who can manage the underlying condition without re-introducing dependency-forming supportive care.
- Aftercare: continued structured programme including supportive care monitoring, outpatient counselling, and family sessions.
A specific feature of prescription drug treatment is that the original health condition often still needs treatment. A person dependent on support for anxiety is not anxiety-free once off support. The anxiety needs to be addressed — with non-dependency-forming supportive care where appropriate, with therapy, with lifestyle intervention. This is why discharge handover to a psychiatrist or physician matters so much in this population.
The first step is an assessment, not confrontation. Bring the supportive care, the prescriptions if available, and your own observations. Our admissions team will walk you through whether what you are describing is clinical dependency and what treatment would look like. First call is confidential.
- Prescription drug dependency is substantially under-recognised in Indian families because everyone assumes "the doctor started it" means it is fine. Often it is not.
- The four categories that matter: opioid painkillers (opioid or sedative misuse, prescription substance), sedatives (sedative substance misuse), prescription substanceoids (prescription substance, prescription substance), and stimulants (prescription substance, prescription substance).
- Sedative withdrawal can be clinically serious and can produce seizures. Stopping suddenly without supervision is contraindicated.
- Dependency typically develops from a real clinical need through a series of small, reasonable-looking decisions — not through recreational misuse.
- Treatment combines clinically supervised support with therapy and requires a handover plan for the original health condition the supportive care was treating.
- If your family member is on sedatives and wants to stop, that conversation should happen with a psychiatrist, not at the kitchen table.
